Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 90,000 shares at $81.17 ($7.3M) on 2014-02-14, disclosed to the SEC on 2014-02-19.
Scheduled sale ($7.3M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.17 | 72,514 | $5.9M | 80.4% |
| 2 | $81.99 | 13,586 | $1.1M | 15.2% |
| 3 | $82.75 | 3,900 | $323K | 4.4% |
| Total | $81.36 avg | 90,000 | $7.3M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |